Puma Biotechnology | PBYI - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Biogen USD 3.38B 374.2M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Esperion Therapeutics USD 156.16M 11.69M 2026-03
Exelixis USD 226.15M 256.34M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Glaxosmithkline GBP 3.44B 146M 2026-03
Incyte USD 4.02B 435.22M 2026-03
MacroGenics USD 66.52M 9.3M 2026-03
Moderna USD 1.91B 687M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
PTC Therapeutics USD 833.99M 150.66M 2026-03
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Takeda JPY 654.94B 26.55B 2025-12
TG Therapeutics USD 442.21M 242.7M 2026-03
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03